Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19]

Volume: 191, Pages: 156 - 159
Published: Jul 1, 2020
Abstract
The authors regret that panel E of Fig. 1 was missing, showing the cumulative incidence of the primary outcome in hematologic cancer.Fig. 1Cumulative incidence of the primary outcome (composite of first recurrent VTE or first major bleeding) in patients with gastrointestinal (panel A), lung (panel B), urogenital (panel C), breast (D), hematologic (panel E), or gynecologic cancer (panel F) during the 12-month study period.View Large Image Figure...
Paper Details
Title
Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19]
Published Date
Jul 1, 2020
Volume
191
Pages
156 - 159
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.